Related Experiment Video
Updated: Sep 20, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Developing and validating a diagnostic threshold for central blood pressure in assessing cardiovascular risks
Shuqi Wang1, Samuel Y S Wong1, Benjamin H K Yip1
1JC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, JC School of Public Health and Primary Care, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.
Insights
A new threshold for central blood pressure (cBP) was established at 135 mmHg. Central hypertension, even without brachial hypertension, significantly increases cardiovascular disease (CVD) risk, improving risk prediction beyond traditional measures.
Area of Science:
- Cardiology
- Hypertension Research
- Preventive Medicine
Background:
- Traditional blood pressure (BP) measurements may not fully capture cardiovascular disease (CVD) risk.
- Central blood pressure (cBP) offers a more direct assessment of arterial load.
- Establishing outcome-derived thresholds for cBP is crucial for clinical application.
Purpose of the Study:
- To establish an outcome-derived threshold for central blood pressure (cBP).
- To evaluate the clinical utility of cBP in stratifying cardiovascular disease (CVD) risk.
- To compare CVD risk associated with different combinations of brachial and central BP levels.
Main Methods:
- Retrospective cohort study of 34,289 adults from the UK Biobank.
- Primary endpoint: composite of cardiovascular mortality and non-fatal cardiovascular events.
- Developed cBP diagnostic threshold using bootstrap and approximation methods; employed Cox regression for risk prediction analysis.
Main Results:
- Established a central systolic blood pressure (SBP) threshold of 135 mmHg, corresponding to a brachial SBP threshold of 140 mmHg.
- Identified distinct risk categories: concordant normotension (49.84%), isolated brachial hypertension (2.23%), isolated central hypertension (3.65%), and concordant hypertension (44.28%).
- Isolated central hypertension (HR 1.70) and concordant hypertension (HR 1.51) showed significantly elevated CVD risk compared to normotension. Inclusion of cBP improved CVD risk prediction models.
Conclusions:
- A central SBP diagnostic threshold of 135 mmHg is proposed.
- Elevated central hypertension signifies increased CVD risk, irrespective of brachial blood pressure status.
- Integrating central BP measurements enhances cardiovascular risk prediction beyond conventional brachial BP assessments.
Aims:
This study aimed to establish an outcome-derived threshold for central blood pressure (cBP) and evaluate its clinical utility in stratifying cardiovascular (CVD) risk.
Methods And Results:
A retrospective cohort study of 34 289 adults without prior CVD was conducted using the UK Biobank dataset. The primary endpoint was a composite of cardiovascular mortality and non-fatal cardiovascular events. Diagnostic threshold for cBP was developed by bootstrap and approximation methods, based on the current brachial BP. Cox regression models were employed to evaluate the clinical utility of diagnostic thresholds for cBP in predicting in CVD. A diagnostic threshold of 135 mmHg for central systolic blood pressure (SBP) corresponded to the threshold of 140 mmHg for brachial SBP. Simultaneous assessment of brachial and central SBP configurated following categories: brachial and central normotension (49.84%), isolated brachial hypertension (2.23%), isolated central hypertension (3.65%) and concordant brachial and central hypertension (44.28%). Compared with concordant normotension, hazard ratios for cardiovascular events were 0.81 (0.45, 1.44) for isolated brachial hypertension, 1.70 (1.23, 2.35) for isolated central hypertension and 1.51 (1.30, 1.76) for concordant hypertension. The inclusion of cBP improved model fit and discrimination for predicting CVD beyond brachial BP alone.
Conclusion:
This study established a diagnostic threshold of 135 mmHg for central SBP. Individuals with central HT exhibited elevated risks of CVD, regardless of brachial HT status. Incorporating central BP enhanced the prediction of CVD risk beyond traditional BP measurement alone.
Related Concept Videos
Pre-Procedural Guidelines for Assessing Blood Pressure
Errors occurring during blood pressure monitoring
Several factors...
Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Hypertension III: Clinical Manifestations and Diagnostic Studies
Assessment of blood pressure in brachial artery(two-step method)
Assessment of blood pressure in brachial artery(one-step method)
Prepare for the Procedure:

